Navigation Links
Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit

WINSTON-SALEM, N.C., May 1 /PRNewswire-FirstCall/ -- The Oregon State Supreme Court today issued its ruling in Lowe, a proposed statewide class action in which plaintiff sought to make cigarette manufacturers, including R. J. Reynolds Tobacco Company, pay for medical monitoring of all Oregon cigarette smokers.

The court ruled that the trial court's dismissal of the complaint and the intermediate appellate court's unanimous decision affirming that ruling were correct.

"We are pleased with the Court's decision," said Martin L. Holton III -- general counsel for R.J. Reynolds.

R.J. Reynolds Tobacco Company, an indirect subsidiary of Reynolds American Inc. (NYSE: RAI), is the second-largest tobacco company in the United States, manufacturing about one of every three cigarettes sold in the country. The company's brands include five of the 10 best-selling U.S. cigarette brands: Camel, Kool, Pall Mall, Winston and Doral. For more information, visit .

SOURCE R.J. Reynolds Tobacco Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
2. Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center
3. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
4. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
5. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
6. The First Mega-Shelter Arrangement in Oregon Created for Major Disaster Response and Recovery
7. New Report: Increasing Oregons Cigarette Tax Will Reduce Smoking, Save Lives and Save Money
8. Big Tobacco Spends Record $12 Million to Deceive Oregon Voters
9. Tobacco Industry Puts Profits Before Kids in Defeating Oregon Ballot Initiative
10. TriWest Contributes $30,000 to Oregon National Guard Fund
11. Oregon researchers find trigger gene for muscle development
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... 7th Annual 2015 Golden Bridge Business Awards under the New Products and Services ... capex web based sample management software that helps labs organize data ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech North ... Gary has spent a significant amount of time in Sweden since joining PartnerTech ...
(Date:12/1/2015)... ... December 01, 2015 , ... Tympani ... Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as having fulfilled ... Contact Center solutions targeted to the high-end enterprise contact center marketplace. , Ed ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: